Axsome Therapeutics Inc
NASDAQ:AXSM

Watchlist Manager
Axsome Therapeutics Inc Logo
Axsome Therapeutics Inc
NASDAQ:AXSM
Watchlist
Price: 98.0819 USD 0.26%
Market Cap: 4.7B USD
Have any thoughts about
Axsome Therapeutics Inc?
Write Note

Net Margin
Axsome Therapeutics Inc

-105.9%
Current
-255%
Average
4.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-105.9%
=
Net Income
-308.6m
/
Revenue
291.5m

Net Margin Across Competitors

Country US
Market Cap 4.7B USD
Net Margin
-106%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 758.2B USD
Net Margin
20%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.3T DKK
Net Margin
35%
Country US
Market Cap 367.6B USD
Net Margin
17%
Country US
Market Cap 250.1B USD
Net Margin
19%
Country CH
Market Cap 208.5B CHF
Net Margin
20%
Country CH
Market Cap 181.2B CHF
Net Margin
33%
Country UK
Market Cap 159.6B GBP
Net Margin
13%
Country IE
Market Cap 155B USD
Net Margin
-126%

Profitability Report

View the profitability report to see the full profitability analysis for Axsome Therapeutics Inc.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-105.9%
=
Net Income
-308.6m
/
Revenue
291.5m
What is the Net Margin of Axsome Therapeutics Inc?

Based on Axsome Therapeutics Inc's most recent financial statements, the company has Net Margin of -105.9%.